ILMN vs VRTX · rev $2.25B vs P/E 30, rev $3.33B
Illumina Inc (ILMN) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ILMN currently screens at market cap $15.84B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ILMN and VRTX stock pages for the full models.
Not investment advice.